Downstreaming and purification of lovastatin from Monascus purpureus culture

Thai Journal of Pharmaceutical Sciences

Volumn 33, Issue 1, 2009, Pages 39-46

  Ahmad, Ajaz ^a   Panda, Bibhu Prasad ^a   Khan, Shamshir ^a   Ali, Mohd ^a   Javed, Saleem ^b  

^a HAMDARD UNIVERSITY   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

In toto culture; Lovastatin; Monascus purpureus; Overloaded elution chromatography; Purification

Indexed keywords

ACETIC ACID ETHYL ESTER; ACETONITRILE; BENZENE; CHLOROFORM; MEVINOLIN; PHOSPHORIC ACID; SILICA GEL; TRIFLUOROACETIC ACID;

ARTICLE; CHROMATOGRAPHY; CULTURE MEDIUM; DOWNSTREAM PROCESSING; DRUG DETERMINATION; DRUG ISOLATION; DRUG PURIFICATION; DRUG STRUCTURE; ELUTION; FUNGUS CULTURE; MONASCUS; NONHUMAN;

EID: 77953390051     PISSN: 01254685     EISSN: 19054637     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. A.W. Alberts, J. Chen, G. Kuron, V. Hunt, J. Huff, C. Hoffman, J. Rothrock, M. Lopez, H. Joshua, E. Harris, A. Patchett, R. Monaghan, S. Currie, E. Stapley, G. Albers-Schonberg, O. Hensens, J. Hirshfield, K. Hoogsteen, J. Liesch, and J. Springer. Mevinolin: a highly potent competitive inhibitor of hydroxymethyl glutaryl coenzyme A reductase and cholesterol lowering agent, Proc. Natl. Acad. Sci. USA 77: 3957-3961 (1980).
2. A. Endo. Monacolin K, a new hypocholesterolemic agent produced by a Monascus species, J. Antibiot. 32: 852-854 (1979).
3. M Manzoni, and M. Rollini. Biosynthesis and biotechnological production of statins by filamentous fungi and applications of these cholesterol-lowering drugs, Appl. Microbiol. Biotechnol. 58: 555-564 (2002).
4. J.A. Tobert. Lovastatin and beyond: the history of the HMG CoA reductase inhibitors, Nat. Rev. Drug Discov. 2: 517-526 (2003).
5. J.J. Wang, C.L. Lee, and T.M. Pan. Improvement of monacolin K, γ-amino butyric acid and citrinin production ratio as a function of environmental conditions of Monascus purpureus NTU 601, J. Ind. Microbiol. Biotechnol. 30:669-676(2003).
6. Y.C. Su, J.J. Wang, T.T. Lin, and T.M. Pan. Production of secondary metabolites, γ-amino butyric acid and monacolin K by Monascus, J. Ind. Microbiol. Biotechnol. 30: 41-46 (2003).
7. C.L. Lee, J.J.Wang, S.L. Kuo, and T.M. Pan. Monascus fermentation of dioscorea for increasing the production of cholesterol-lowering agent-monacolin K and antiinflammation agent-monascin, Appl. Microbiol. Biotechnol. 72:1254-1262 (2006).
8. S. A. Sayyad, B.P. Panda, S. Javed, and M. Ali. Optimization of nutrient parameters for lovastatin production by Monascus purpureus MTCC 369 under submerged fermentation using response surface methodology, Appl. Microbiol. Biotechnol. 73:1054-1058 (2007).
9. T. Miyake, K. Uchitomi, M.Y. Zhang, I. Kono, N. Nozaki, H. Sammoto, and K. Inagaki. Effects of the principal nutrients on lovastatin production by Monascus pilosus, Biosci. Biotechnol. Biochem. 70: 1154-1159 (2006).
10. H. Hajjaj, P. Niedberger, and P. Duboc. Lovastatin biosynthesis by Aspergillus terreus in a chemically defined medium, Appl. Environ. Microbiol. 67: 2596-2604 (2001).
11. E.M.R. Porcel, J.L.C. Lopez, M.A.V. Ferron, J.A.S. Perez, J.L.G. Sanchez, and Y. Chisti. Effects of the sporulation conditions on the lovastatin production by Aspergillus terreus, Bioprocess. Biosyst. Eng. 29: 1-5 (2006).
12. H.R. Valera, J. Gomes, S. Lakshmi, R. Gururaja, S. Suryanarayan, and D. Kumar. Lovastatin production by SSF using Aspergillus flavipes, Enz. Microb. Tech. 37: 521-526 (2005).
13. S.M. Samiee, N. Moazami, S. Haghighi, F.A. Mohseni, S. Mirdamadi, and M.R. Bakhtiari. Screening of lovastatin production by filamentous fungi, Iran Biomed. J. 7: 29-33 (2003).
14. M. Manzoni, S. Bergomi, M. Rollini, and V. Cavazzoni. Production and purification of statins from Aspergillus terreus strains, Biotechnol. Tech. 12:529-532 (1998).
15. D.A. Skoog, F.J. Holler, and T.A. Nieman. Separation methods. In: Principles of Instrumental Analysis, Saunders College Publishing, Philadelphia, USA, 1998, pp.674-700.
16. J. Mendham, R.C. Denny, J.D. Barnes, and K.J.M. Thomas. Separation. In: Vogel's textbook of Quantitative Chemical Analysis, Pearson Publishing Education Pvt. Ltd., Singapore, 2002, pp.211-225.
17. R.P. Patel, and M.M. Patel, Preparation and evaluation of inclusion complex of the lipid lowering drug lovastatin with ß-cyclodextrin, Dhaka Univ. J. Pharm. Sci. 6: 25-36 (2007).
18. U. Holzgrabe, B.W.K. Diehl, and I.Wawer. NMR spectroscopy in pharmacy, J. Pharm. Biomed. Anal. 17: 557-616 (1998).
19. J. Alarcon, S. Aguila, P.A. Avila, O. Fuentes, E. Z. Ponce, and M.Hernandez. Production and purification of statins from Pleurotus ostreatus (basidiomycetes) strains, Z. Naturforsch. 58c: 62-64 (2003).
20. J. Ma, Y. Li, Q. Ye, J. Li, Y. Hua, D. Ju, D. Zhang, R. Cooper, and M. Chang. Constituents of red yeast rice, a traditional Chinese food and medicine, J. Agric. Food Chem. 48: 5220-5225 (2000).
21. D. Wild, G. Toth, and H.U. Humpf. New Monascus metabolites with a pyridine structure in red fermented rice, J. Agric. Food Chem. 51: 5493-5496 (2003).
22. S. Babitha, C.R. Soccol, and A. Pandey. Effect of stress on growth, pigment production and morphology of Monascus sp. in solid cultures, J. Basic Microbiol. 47: 118-126 (2007).
23. E.M.R. Porcel, J.L.C. Lopez, J.A.S. Perez, and Y. Chisti, Enhanced production of lovastatin in a bubble column by Aspergillus terreus using a two-stage feeding strategy, J. Chem. Technol. Biotechnol. 82: 58-64 (2007).
24. J.L.C. Lopez, J.A.S. Perez, J.M.F. Sevilla, F.G.A. Fernandez, E.M. Grima, and Y. Chisti, Fermentation optimization for the production of lovastatin by Aspergillus terreus: use of response surface methodology, J. Chem. Technol. Biotechnol. 79:1119-1126 (2004).